Podchaser Logo
Home
Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

Released Wednesday, 15th May 2024
Good episode? Give it some love!
Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

Wednesday, 15th May 2024
Good episode? Give it some love!
Rate Episode

Host: Jhanelle E. Gray, MD

In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features